vs

Side-by-side financial comparison of OMNICELL, INC. (OMCL) and Verisign (VRSN). Click either name above to swap in a different company.

Verisign is the larger business by last-quarter revenue ($425.3M vs $309.9M, roughly 1.4× OMNICELL, INC.). Verisign runs the higher net margin — 48.5% vs 3.7%, a 44.8% gap on every dollar of revenue. On growth, OMNICELL, INC. posted the faster year-over-year revenue change (14.9% vs 7.6%). Verisign produced more free cash flow last quarter ($285.1M vs $38.6M). Over the past eight quarters, OMNICELL, INC.'s revenue compounded faster (5.8% CAGR vs 5.2%).

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

Verisign, Inc. is an American company based in Reston, Virginia, that operates a diverse array of network infrastructure, including two of the Internet's thirteen root nameservers, the authoritative registry for the .com, .net, and .name generic top-level domains and the .cc country-code top-level domains, and the back-end systems for the .jobs and .edu sponsored top-level domains.

OMCL vs VRSN — Head-to-Head

Bigger by revenue
VRSN
VRSN
1.4× larger
VRSN
$425.3M
$309.9M
OMCL
Growing faster (revenue YoY)
OMCL
OMCL
+7.3% gap
OMCL
14.9%
7.6%
VRSN
Higher net margin
VRSN
VRSN
44.8% more per $
VRSN
48.5%
3.7%
OMCL
More free cash flow
VRSN
VRSN
$246.5M more FCF
VRSN
$285.1M
$38.6M
OMCL
Faster 2-yr revenue CAGR
OMCL
OMCL
Annualised
OMCL
5.8%
5.2%
VRSN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
OMCL
OMCL
VRSN
VRSN
Revenue
$309.9M
$425.3M
Net Profit
$11.4M
$206.2M
Gross Margin
45.3%
88.5%
Operating Margin
60.1%
67.0%
Net Margin
3.7%
48.5%
Revenue YoY
14.9%
7.6%
Net Profit YoY
7.7%
EPS (diluted)
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OMCL
OMCL
VRSN
VRSN
Q1 26
$309.9M
Q4 25
$314.0M
$425.3M
Q3 25
$310.6M
$419.1M
Q2 25
$290.6M
$409.9M
Q1 25
$269.7M
$402.3M
Q4 24
$306.9M
$395.4M
Q3 24
$282.4M
$390.6M
Q2 24
$276.8M
$387.1M
Net Profit
OMCL
OMCL
VRSN
VRSN
Q1 26
$11.4M
Q4 25
$206.2M
Q3 25
$5.5M
$212.8M
Q2 25
$5.6M
$207.4M
Q1 25
$-7.0M
$199.3M
Q4 24
$191.5M
Q3 24
$8.6M
$201.3M
Q2 24
$3.7M
$198.8M
Gross Margin
OMCL
OMCL
VRSN
VRSN
Q1 26
45.3%
Q4 25
41.5%
88.5%
Q3 25
43.3%
88.4%
Q2 25
43.9%
88.0%
Q1 25
41.1%
87.7%
Q4 24
46.2%
87.8%
Q3 24
43.3%
88.0%
Q2 24
41.3%
87.8%
Operating Margin
OMCL
OMCL
VRSN
VRSN
Q1 26
60.1%
Q4 25
0.1%
67.0%
Q3 25
2.7%
67.8%
Q2 25
2.8%
68.5%
Q1 25
-4.3%
67.4%
Q4 24
4.0%
66.7%
Q3 24
2.3%
68.9%
Q2 24
1.2%
68.8%
Net Margin
OMCL
OMCL
VRSN
VRSN
Q1 26
3.7%
Q4 25
48.5%
Q3 25
1.8%
50.8%
Q2 25
1.9%
50.6%
Q1 25
-2.6%
49.5%
Q4 24
48.4%
Q3 24
3.1%
51.5%
Q2 24
1.3%
51.4%
EPS (diluted)
OMCL
OMCL
VRSN
VRSN
Q1 26
$0.25
Q4 25
$-0.05
Q3 25
$0.12
Q2 25
$0.12
Q1 25
$-0.15
Q4 24
$0.34
Q3 24
$0.19
Q2 24
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OMCL
OMCL
VRSN
VRSN
Cash + ST InvestmentsLiquidity on hand
$239.2M
$580.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.3B
$-2.2B
Total Assets
$2.0B
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OMCL
OMCL
VRSN
VRSN
Q1 26
$239.2M
Q4 25
$196.5M
$580.5M
Q3 25
$180.1M
$617.7M
Q2 25
$399.0M
$593.8M
Q1 25
$386.8M
$648.5M
Q4 24
$369.2M
$599.9M
Q3 24
$570.6M
$644.9M
Q2 24
$556.8M
$689.9M
Stockholders' Equity
OMCL
OMCL
VRSN
VRSN
Q1 26
$1.3B
Q4 25
$1.2B
$-2.2B
Q3 25
$1.2B
$-2.1B
Q2 25
$1.3B
$-2.0B
Q1 25
$1.3B
$-2.0B
Q4 24
$1.2B
$-2.0B
Q3 24
$1.2B
$-1.9B
Q2 24
$1.2B
$-1.8B
Total Assets
OMCL
OMCL
VRSN
VRSN
Q1 26
$2.0B
Q4 25
$2.0B
$1.3B
Q3 25
$1.9B
$1.4B
Q2 25
$2.1B
$1.4B
Q1 25
$2.2B
$1.4B
Q4 24
$2.1B
$1.4B
Q3 24
$2.3B
$1.5B
Q2 24
$2.3B
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OMCL
OMCL
VRSN
VRSN
Operating Cash FlowLast quarter
$54.5M
$289.6M
Free Cash FlowOCF − Capex
$38.6M
$285.1M
FCF MarginFCF / Revenue
12.5%
67.0%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
4.80×
1.40×
TTM Free Cash FlowTrailing 4 quarters
$110.8M
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OMCL
OMCL
VRSN
VRSN
Q1 26
$54.5M
Q4 25
$30.4M
$289.6M
Q3 25
$28.3M
$307.7M
Q2 25
$42.8M
$202.5M
Q1 25
$25.9M
$291.3M
Q4 24
$56.3M
$231.5M
Q3 24
$22.8M
$253.4M
Q2 24
$58.7M
$160.4M
Free Cash Flow
OMCL
OMCL
VRSN
VRSN
Q1 26
$38.6M
Q4 25
$22.6M
$285.1M
Q3 25
$18.5M
$303.0M
Q2 25
$31.0M
$194.7M
Q1 25
$14.8M
$285.5M
Q4 24
$47.2M
$222.0M
Q3 24
$13.9M
$247.8M
Q2 24
$49.1M
$151.2M
FCF Margin
OMCL
OMCL
VRSN
VRSN
Q1 26
12.5%
Q4 25
7.2%
67.0%
Q3 25
6.0%
72.3%
Q2 25
10.7%
47.5%
Q1 25
5.5%
71.0%
Q4 24
15.4%
56.1%
Q3 24
4.9%
63.4%
Q2 24
17.8%
39.1%
Capex Intensity
OMCL
OMCL
VRSN
VRSN
Q1 26
Q4 25
2.5%
1.1%
Q3 25
3.1%
1.1%
Q2 25
4.1%
1.9%
Q1 25
4.1%
1.4%
Q4 24
3.0%
2.4%
Q3 24
3.1%
1.4%
Q2 24
3.5%
2.4%
Cash Conversion
OMCL
OMCL
VRSN
VRSN
Q1 26
4.80×
Q4 25
1.40×
Q3 25
5.18×
1.45×
Q2 25
7.58×
0.98×
Q1 25
1.46×
Q4 24
1.21×
Q3 24
2.64×
1.26×
Q2 24
15.72×
0.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OMCL
OMCL

Product revenues$174.8M56%
Service revenues$135.1M44%

VRSN
VRSN

Segment breakdown not available.

Related Comparisons